The Food and Drug Adminstration said Thursday that it is requiring makers of Botox and rival products to display tougher warnings on their labels advising the products may trigger certain dangerous side effects. The boxed warning is the strongest the FDA can impose on a prescription drug without asking it be withdrawn from the market.
Read full story via MarketWatch.
Discussion
No comments for “FDA toughens warnings on Botox-like products”